Cargando…
Kinetics of Wound Development and Healing Suggests a Skin-Stabilizing Effect of Allogeneic ABCB5(+) Mesenchymal Stromal Cell Treatment in Recessive Dystrophic Epidermolysis Bullosa
Recessive dystrophic epidermolysis (RDEB) is a rare, inherited, and currently incurable skin blistering disorder characterized by cyclically recurring wounds coexisting with chronic non-healing wounds. In a recent clinical trial, three intravenous infusions of skin-derived ABCB5(+) mesenchymal strom...
Autores principales: | Niebergall-Roth, Elke, Dieter, Kathrin, Daniele, Cristina, Fluhr, Silvia, Khokhrina, Maria, Silva, Ines, Ganss, Christoph, Frank, Markus H., Kluth, Mark A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252830/ https://www.ncbi.nlm.nih.gov/pubmed/37296590 http://dx.doi.org/10.3390/cells12111468 |
Ejemplares similares
-
Corrigendum to ABCB5+ mesenchymal stromal cells facilitate complete
and durable wound closure in recessive dystrophic epidermolysis bullosa
[Cytotherapy 25 (2023) 782–788/1562]
por: Dieter, Kathrin, et al.
Publicado: (2023) -
Clinical trial of ABCB5(+) mesenchymal stem cells for recessive dystrophic epidermolysis bullosa
por: Kiritsi, Dimitra, et al.
Publicado: (2021) -
Dystrophic Epidermolysis Bullosa
por: Yadav, Randhir Sagar, et al.
Publicado: (2018) -
Quality of Life and Economic Burden in Recessive Dystrophic Epidermolysis Bullosa
por: Jeon, In Kyung, et al.
Publicado: (2016) -
Peripheral neuro-immune pathology in recessive dystrophic epidermolysis bullosa
por: Mack, Madison, et al.
Publicado: (2014)